Zeber-Lubecka, N., Kulecka, M., Ambrozkiewicz, F., Paziewska, A., Goryca, K., Karczmarski, J., . . . Ostrowski, J. (2016). Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes.
Citação norma ChicagoZeber-Lubecka, Natalia, et al. "Limited Prolonged Effects of Rifaximin Treatment On Irritable Bowel Syndrome-related Differences in the Fecal Microbiome and Metabolome." Gut Microbes 2016.
MLA CitationZeber-Lubecka, Natalia, et al. "Limited Prolonged Effects of Rifaximin Treatment On Irritable Bowel Syndrome-related Differences in the Fecal Microbiome and Metabolome." Gut Microbes 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.